Vanderbilt University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Vanderbilt University sits in the top decile of US sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count).
Vanderbilt University: 430 sponsored US clinical trials, 15 recruiting.
Vanderbilt University sponsors 430 registered US clinical trials on ClinicalTrials.gov, 15 of them currently recruiting, and 343 completed. 42 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.
Top-decile sponsor footprint
Vanderbilt University ranks in the top decile of sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
343 of 401 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
430 total, page 4 of 9
Promoting Adherence to Lymphedema Self-care
NCT01779063
High Sodium Diet and External Abdominal Compression in POTS
NCT01771484
Forces During Skull Base Surgery
NCT01705821
RIFL (Rigid and Flexing Laryngoscope) vs. Fiberoptic Bronchoscope
NCT01965938
Effect of Ticagrelor vs. Dipyridamole on Adenosine Uptake
NCT01690884
Inflammation and the Heart
NCT01589770
Characterizing Hemodynamic Compensation in Patients With Intracranial Stenosis
NCT02506907
Citrulline in Severe Sepsis
NCT01474863
Genetic Variation in Platelet Aggregation
NCT01576536
Daily Chlorhexidine Bathing and Infection Rates in Critically-ill Patients
NCT02033187
Magnetic Resonance Spectroscopy in Autonomic Failure
NCT01607268
The Impact of Telemedicine on Orthopaedic Trauma Patients With Closed Fractures
NCT01991782
Targeting Social Determinants to Improve Chronic Kidney Disease Care
NCT01604577
Comparison of Perineural Catheter Depth for the Continuous Popliteal Nerve Block Using Ultrasound Guidance and Dermabond
NCT01591603
My MediHealth: A Paradigm for Children-centered Medication Management
NCT01730235
Delirium in the Emergency Department and Its Extension Into Hospitalization
NCT01651897
Esophageal Monitoring Device for Assessing Mucosal Impedance
NCT01556919
Dietary Salt in Postural Tachycardia Syndrome
NCT01547117
Resveratrol-Leucine Metabolite Synergy in Pre-diabetes
NCT01593605
Cognitive-Behavioral Physical Therapy
NCT01131611
RYGB and the Gastric Adipose Axis
NCT01474785
Pharmacogenetics of Ace Inhibitor-Associated Angioedema
NCT01413542
Endophthalmitis Cultures
NCT01496794
Percutaneous Cochlear Implantation: Implementation of Technique
NCT01460823
Impact of Postoperative Management on Outcomes and Healing of Rotator Cuff Repairs
NCT01383239
Standard Dose Versus High-Dose Inactivated Flu Vaccine in Pediatric Solid Organ Transplant Patients
NCT01525004
Multicenter Blood Culture Quality Improvement
NCT01413555
DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Traumatic Brain Injury
NCT01322048
Renin-Angiotensin and Fibrinolysis in Humans: Effect of Long-Term PDE5 Inhibition on Glucose Homeostasis
NCT01409993
Inhibition of Lipid Peroxidation During Cardiac Surgery
NCT01366976
Growing Right Onto Wellness (GROW): Changing Early Childhood Body Mass Index (BMI) Trajectories
NCT01316653
Educational Intervention to Improve Vaccine Acceptance
NCT01385501
Factors Involved in Obesity-related Inflammation and Insulin Resistance
NCT01173705
Bioelectrical Impedance for Self-monitoring of Lymphedema
NCT01385488
The Public Private Partnership Addressing Literacy-Numeracy to Improve Diabetes Care
NCT01344668
Cognitive Dysfunction in Postural Tachycardia Syndrome
NCT01366963
Peri-Anesthetic Imaging of Cognitive Dysfunction
NCT01322672
Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer
NCT01326286
A Comparison of Dilute Versus Concentrated Heparin for CRRT Anticoagulation
NCT01318811
Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure
NCT01292694
ACT-ICU Study: Activity and Cognitive Therapy in the Intensive Care Unit
NCT01270269
Improving Patient Satisfaction Improving Patient Satisfaction
NCT01263639
Can We Predict Who Has Gastroesophageal Reflux Disease (GERD)?
NCT01204931
Cough Monitoring Study
NCT01263626
Oxidative Stress in Chronic Kidney Disease: Diet and Exercise
NCT01150851
Standard Versus High-Dose Trivalent Inactivated Flu Vaccine in Pediatric Acute Lymphoblastic Leukemia Patients
NCT01216332
The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
NCT01119196
Inhaled Iloprost in Mild Asthma
NCT01209533
Cell Mediated Immunity in Older Adults
NCT01189123
Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study
NCT01162356
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 50 |
| Phase 2 | 42 |
| Phase 3 | 10 |
| Phase 4 | 32 |
Therapeutic Areas
What is open in the Vanderbilt University pipeline
15 recruiting of 430 indexed (3% open); 343 completed (80%).
Phase mix: 42 late (III/IV) vs 92 early (I/II) (early-phase heavy).
Top condition: Obesity (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Vanderbilt University: open-pipeline peers nationwide
Peers matched on 430 registered trials and 3% open enrollment, not the therapeutic-area sidebar.
Vanderbilt University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 430 trials (± recruiting share)
- University of Illinois at Chicago · 430 trials · 27% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
- Dartmouth-Hitchcock Medical Center · 427 trials · 12% recruiting
Sponsors near 3% open enrollment (± trial volume)
- USDA Grand Forks Human Nutrition Research Center · 4% recruiting · 57 trials
- Medtronic MiniMed · 3% recruiting · 29 trials
- Sandoz · 3% recruiting · 29 trials
- Sonova · 3% recruiting · 29 trials
Related
What to do with this Vanderbilt University page
430 registered trials is a research-attention snapshot, not an endorsement of Vanderbilt University or any single study.
- 15 of Vanderbilt University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Vanderbilt University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Vanderbilt University pipeline card: 430 registered trials from official public datasets.Report a data error.